We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$481B
AUM Growth
-$11.2B
Cap. Flow
+$6.33B
Cap. Flow %
1.32%
Top 10 Hldgs %
27.75%
Holding
13,532
New
1,585
Increased
5,250
Reduced
4,926
Closed
1,614

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.26B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12B
3
AAPL icon
Apple
AAPL
+$986M
4
AMZN icon
Amazon
AMZN
+$676M
5
KVUE icon
Kenvue
KVUE
+$501M

Sector Composition

Rank Sector Weight
1 Technology 2.36%
2 Consumer Discretionary 1.65%
3 Financials 1.08%
4 Healthcare 0.89%
5 Communication Services 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODX
11551
PUT
Co-Diagnostics
CODX
$7.69M
$19.3K ﹤0.01%
607
+30
+5% +$1.13K
EVTL icon
11552
PUT
Vertical Aerospace
EVTL
$133M
$19.2K ﹤0.01%
1,630
+10
+0.6% +$154
DYAI icon
11553
CALL
Dyadic International
DYAI
$27.7M
$19.2K ﹤0.01%
10,000
-1,700
-15% -$3.17K
CMRX
11554
PUT
DELISTED
Chimerix, Inc.
CMRX
$19.2K ﹤0.01%
+20,000
New +$21.8K
UXIN
11555
Uxin Ltd
UXIN
$260M
$19.1K ﹤0.01%
1,175
-3,489
-75% -$56.8K
REAX icon
11556
CALL
Real Brokerage
REAX
$620M
$19.1K ﹤0.01%
+1,320
New +$23K
NUVB icon
11557
Nuvation Bio
NUVB
$2.49B
$19.1K ﹤0.01%
14,222
-31,881
-69% -$53.1K
AQST icon
11558
PUT
Aquestive Therapeutics
AQST
$638M
$19K ﹤0.01%
+12,400
New +$21.3K
CDTX
11559
CALL
DELISTED
Cidara Therapeutics
CDTX
$18.8K ﹤0.01%
+1,000
New +$19.6K
AQST icon
11560
Aquestive Therapeutics
AQST
$638M
$18.7K ﹤0.01%
12,217
-80,982
-87% -$139K
KTTA icon
11561
Pasithea Therapeutics
KTTA
$18.7M
$18.5K ﹤0.01%
+1,928
New +$21.1K
RCG
11562
RENN Fund
RCG
$20.6M
$18.4K ﹤0.01%
+10,300
New +$18.8K
ZFOX
11563
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$18.4K ﹤0.01%
20,882
+466
+2% +$499
INM icon
11564
InMed Pharmaceuticals
INM
$7.69M
$18.3K ﹤0.01%
1,329
+645
+94% +$11.8K
SPRU icon
11565
CALL
Spruce Power Holding Corp
SPRU
$41.2M
$18.2K ﹤0.01%
3,350
-1,525
-31% -$10.1K
FTCI icon
11566
CALL
FTC Solar
FTCI
$32.9M
$18.2K ﹤0.01%
1,420
-1,260
-47% -$30.5K
LIAN
11567
DELISTED
LianBio American Depositary Shares
LIAN
$18.1K ﹤0.01%
+12,175
New +$23.2K
VCSA
11568
CALL
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$18K ﹤0.01%
1,960
-310
-14% -$3.77K
DNA.WS
11569
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$18K ﹤0.01%
80,132
+25,777
+47% +$6.92K
GAN
11570
PUT
DELISTED
GAN Ltd
GAN
$18K ﹤0.01%
+15,500
New +$24.4K
TUP
11571
DELISTED
Tupperware Brands Corporation
TUP
$17.9K ﹤0.01%
12,819
-137,348
-91% -$308K
MREO
11572
PUT
Mereo BioPharma
MREO
$45M
$17.8K ﹤0.01%
13,800
-6,500
-32% -$8.62K
ZTEK
11573
Zentek
ZTEK
$76.2M
$17.7K ﹤0.01%
+14,076
New +$20.4K
NNVC icon
11574
CALL
NanoViricides
NNVC
$32.9M
$17.6K ﹤0.01%
+13,100
New +$18.5K
BSQR
11575
CALL
DELISTED
BSQUARE Corporation
BSQR
$17.4K ﹤0.01%
14,600
-200
-1% -$243

Similar funds

Jeff Yass's Q3 2023 Portfolio in Review

As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
  • Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
  • Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
  • Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
  • Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
  • Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.